Results 191 to 200 of about 2,314,937 (397)
Clinical study on treatment of rectal carcinoma with Chinese Herbal medicine and high dose fluorouracil emulsion via rectal infusion [PDF]
Chenguang Wang+4 more
openalex +1 more source
Abstract Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1, approved in Japan for the treatment of relapsed/refractory peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma. This Phase I, open‐label study evaluated the pharmacokinetics and safety of a single 50‐mg oral dose of valemetostat in
Masaya Tachibana+8 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana+6 more
wiley +1 more source
Clinical observation on treatment of postcardiotomic complications with Chinese herbal medicine based on syndrome differentiation in 58 patients with angiocardiopathy [PDF]
Lihong Ma, Zeng-mian Jiao, Ruihua Zhang
openalex +1 more source
Abstract The aim of this study was to evaluate the bioequivalence and safety of a single application of crisaborole ointment to test formulation and reference formulation in healthy subjects under fasting conditions. A total of 32 subjects were included and divided into 2 groups (test‐reference; reference‐test).
Yanchao Wang+9 more
wiley +1 more source
Abstract A pediatric‐friendly powder for oral suspension (PfOS) of tovorafenib, a type II RAF inhibitor, was developed for patients with difficulty swallowing tablets. This open‐label, randomized, phase 1 study (QSC205140) evaluated the taste/palatability of PfOS formulations (n = 12), the relative bioavailability of the PfOS versus tablet formulation,
Yang Zhang+6 more
wiley +1 more source
Herbal Medicine: Current Trends and Future Prospects
Devendra Kumar+4 more
semanticscholar +1 more source